CDH5 and neoplasm: Myelo-monocytic cells expressing the hematopoietic marker CD14 and various vascular markers such as Tie2 (Tie2+ Monocytes), VE-Cadherin, and VEGFR2 have been reported to take part in both ischemia-associated and tumor-associated angiogenesis [17,20].